New Botox Competitor Approved by FDA
January 12, 2009
Michelle Kosinski reports that the FDA is expected to approve Reloxin – a competitor to Botox.
Topics:
Health Medical Pharma, pharmaceutical industry, Food and Drug Administration, Kosinski, FDA, Botulinum toxin, United States administrative law, Drug safety, Clinical research, Pharmaceutics, Health, Michelle Kosinski, botox